Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P56851 (
epididymal
)
11,273
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A low dose of Cyproterone acetate (
CPA
; 1 mg/kg body weight/day for 70 days) was administered to adult male rhesus monkeys to assess its effects on testicular and
epididymal
structure and function in a nonhuman primate species.
CPA
caused extensive degenerative changes in morphology of seminiferous, efferent duct, and
epididymal
epithelia, including decrease in diameter of seminiferous and
epididymal
tubules and their lumen, height of
epididymal
epithelium, and an increase in intertubular connective tissue. The protein profile of spermatozoa showed alterations during their
epididymal
transit in control and
CPA
-treated monkeys. In
CPA
-treated animals, 19 polypeptides were acquired and nine were eliminated during
epididymal
transit in contrast to acquisition of 12 and loss of 14 polypeptides in control animals. Treatment with
CPA
also resulted in the appearance of 14 new polypeptides in
epididymal
cytosol and luminal fluid, probably of lysosomal origin. The protein pattern of caput and cauda
epididymal
tubule cytosol, maintained in organ culture and exposed to 100 microM
CPA
for 3 days, showed absence of eight polypeptides. These results indicate that even at the low dose used in this study,
CPA
has caused spermatogenic arrest, degenerative changes in the
epididymal
structure, and alterations in
epididymal
and sperm protein profile. Suppression of serum testosterone levels indicates the need for androgen supplementation if
CPA
is to be used for male contraception.
...
PMID:Effect of cyproterone acetate on structure and function of rhesus monkey reproductive organs. 141 98
Studies were conducted to determine the effect of chilling on rat sperm and optimal components (extenders) to avoid chilling-induced injury. In the first experiment, the effects of chilling (at 4, 10, or 22 degrees C) on the motility and acrosomal integrity of
epididymal
sperm from 2 strains of rats (Sprague-Dawley and Fischer 344, F344) were compared. In the second experiment, the motility of
epididymal
Sprague-Dawley rat sperm after exposure to extenders (HEPES-buffered Tyrode lactate, skim milk, lactose monohydrate, Tris-citrate, and TEST) and cooling and warming was determined. We tested the effects of supplementing base extender solutions with 20% lactose-egg yolk (LEY) alone or in combination with a commercial SDS-based paste (0.5%, v/v) in preventing chilling injury. The motility after each treatment was determined after both cooling and warming. In the third experiment, the motility of Sprague-Dawley rat sperm were compared after supplementing the base extenders with either 0.4 M permeating cryoprotective agent (
CPA
; glycerol, ethylene glycol, propylene glycol, or DMSO) or 0.1 M nonpermeating
CPA
(raffinose and sucrose) after cooling and warming. The results showed that chilling significantly reduced the motility-but not acrosomal integrity-of Sprague-Dawley and F344 sperm. Neither motility nor acrosomal integrity differed between Sprague-Dawley and F344 strains. The addition of LEY into each extender significantly prevented motility loss after chilling. These results will be useful during the preparation of optimal extenders and development of successful cryopreservation protocol for rat sperm.
...
PMID:Effect of chilling on the motility and acrosomal integrity of rat sperm in the presence of various extenders. 1980 70